BALLATORE, ZELMIRA
 Distribuzione geografica
Continente #
NA - Nord America 665
EU - Europa 325
AS - Asia 98
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.116
Nazione #
US - Stati Uniti d'America 665
IT - Italia 88
UA - Ucraina 55
SE - Svezia 53
IE - Irlanda 42
CN - Cina 29
DE - Germania 27
TR - Turchia 27
SG - Singapore 23
DK - Danimarca 21
CI - Costa d'Avorio 20
FI - Finlandia 15
GB - Regno Unito 11
KR - Corea 11
IN - India 7
FR - Francia 6
MA - Marocco 6
BE - Belgio 4
AT - Austria 2
EU - Europa 1
JP - Giappone 1
PE - Perù 1
PL - Polonia 1
Totale 1.116
Città #
Chandler 116
Jacksonville 58
Ashburn 57
Dublin 42
Boardman 41
New York 40
Fairfield 36
Wilmington 29
Woodbridge 26
Seattle 24
Centro 22
Abidjan 20
Houston 19
Ancona 18
Des Moines 18
Ann Arbor 16
Cambridge 16
Lawrence 14
Princeton 14
San Mateo 12
Turin 11
Singapore 10
San Diego 8
Pune 7
Guangzhou 5
Washington 5
Beijing 4
Brussels 4
Helsinki 4
Los Angeles 4
Porto 4
Cantu 3
Chiaravalle 3
Dallas 3
London 3
Prescot 3
Wuxi 3
Kilburn 2
Marche 2
Rome 2
Segrate 2
Tolentino 2
Vienna 2
Arequipa 1
Bari 1
Brandenburg 1
Dalian 1
Falconara Marittima 1
Fayetteville 1
Jiaxing 1
Montegiorgio 1
Norwalk 1
Osimo 1
Prudnik 1
Sano 1
Shanghai 1
Shaoxing 1
Suzhou 1
Wuhan 1
Zibo 1
Totale 751
Nome #
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 115
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 105
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 102
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 86
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 82
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer 80
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 76
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 75
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 72
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 72
Patient and caregiver needs in oncology. An Italian survey 70
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 69
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 57
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 51
Cancer patient perspective in the arena of COVID-19 pandemic 37
Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD) 13
Totale 1.162
Categoria #
all - tutte 6.318
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 0 0 0 11 0 12 1 12 2 3 20
2020/2021210 12 22 24 1 25 16 18 16 16 31 20 9
2021/2022108 9 15 2 4 0 9 7 5 7 17 10 23
2022/2023320 22 42 15 26 24 54 0 6 74 2 45 10
2023/2024193 25 6 8 21 27 65 3 4 2 6 1 25
2024/202590 51 26 8 2 3 0 0 0 0 0 0 0
Totale 1.162